MONDAY, Nov. 7, 2022 (HealthDay News) — People have long talked about having near-death experiences in which they felt they were looking down on themselves while others tried to save them. Now researchers have documented some of those experiences. In a new study, investigators found that about 20% of patientsContinue Reading
MONDAY, Nov. 7, 2022 (American Heart Association News) — People with heart disease who forego annual flu vaccination for fear of having an adverse reaction may wish to reconsider. New research finds individuals with high-risk heart disease who experience mild to moderate side effects are less likely to be hospitalizedContinue Reading
MONDAY, Nov. 7, 2022 (HealthDay News) — Infants and children sick with RSV are flooding pediatricians’ offices and children’s hospitals across the United States, due to an early surge of the common childhood virus this year. But within one or two “sick seasons,” doctors expect to have on hand long-soughtContinue Reading
MONDAY, Nov. 7, 2022 (HealthDay News) — The antiviral pill Paxlovid not only reduces hospitalization and death after catching COVID-19: New research shows it also cuts the chances of long COVID by roughly 25%. The drug, which combines a newer antiviral called nirmatrelvir with an older medication known as ritonavir,Continue Reading
MONDAY, Nov. 7, 2022 (HealthDay News) — Folks suffering chest pain from clogged arteries appear to have some true flexibility in choosing the medical care that’s right for them, researchers report. That’s because their overall risk of death is about the same whether they choose aggressive surgical treatment or aContinue Reading
MONDAY, Nov. 7, 2022 (HealthDay News) — As health experts warn about RSV infections in infants and toddlers, adults should know that they, too, can become severely ill from the virus. Respiratory syncytial virus (RSV) is not always the mild respiratory illness people think it is but can lead toContinue Reading
Amid a surge of RSV, hope for new vaccines. As many as four new RSV vaccine candidates could soon be sent for review by the U.S. Food and Drug Administration, experts say, and dozens more are in testing or under development. Read more Is surgery always necessary for chronic chestContinue Reading
MONDAY, Nov. 7, 2022 (HealthDay News) — As the daylight hours shrink, people’s moods can wind up in the tank. Rest assured, you’re not alone. It’s the SAD season for those affected by seasonal affective disorder. That’s the depression, fatigue and withdrawal that shorter days and longer nights often bring.Continue Reading
MONDAY, Nov. 7, 2022 (HealthDay News) — While melanoma remains the most deadly type of skin cancer, new research has found that a subset of patients with early disease are at very low risk of dying. These particular patients may not face the same prognosis that is typically associated withContinue Reading
MONDAY, Nov. 7, 2022 (HealthDay News) — Adult cancer survivors, particularly those who have undergone chemotherapy, have an increased risk for serious pelvic and vertebral fractures, new research shows. “These findings are important as the number of cancer survivors living in the United States is projected to rise to 26.1Continue Reading